The SELECT trial is a game changer. Yes, Novo Nordisk achieved winning results. But obesity patients with heart disease now have a major new drug to extend their lives – and that’s an even bigger win.
Novo Nordisk’s Huge Financial Bet On Obesity Drug Wegovy Wins Big
